Skip to main content

Table 3 Other NMS scales

From: The impact of clinical scales in Parkinson’s disease: a systematic review

S. no.

NMS problems

Different scales of NMS

Features

1

Monitoring for NMS

NMS-Q

There are 30 items in all

Self-sufficient and a yes/no answer

NMS-S

Physician administered 9 domains and having 30 items

Needs rating of frequency (1–4)/severity responses (0–3)

2

Quality of Life

PDQ-39

Assess 39 item

Clinical administrated and covered by questionnaire

3

Autonomic dysfunction

SCOPA

Includes 25 items

No cut-off value is defined

4

Cognitive dysfunction

PD-CRS

Getting 7 activities that are administered by a clinician

Checking for memory issues

SCOPA:CS

Having 10 tasks, clinician-administered

MoCA

To detect mild cognitive impairment and PD dementia

5

Depression

Ham-D

Multiple versions of scale exist, but commonly version of 17 items is mostly used

Self-administered, clinician-administered, and semi-structured forms are all available

BDI

Employs 21 items, self-completed, multiple choice answers

MADRS

Consists of 10 items, clinician-administered

Not usually used

GDS

Anxiety screening service for senior citizens, self-report, yes or no screening instrument

6

Anxiety

STAI

Diagnosing anxiety and differentiating it from depressive disorders

7

Sleep

PDSS

Having 15 items, self-completed

SCOPA: SS

Identifying and evaluating the degree of daytime sleepiness

Uses self-completed 12 items

Looks at signs from the preceding month as well

PSQI

Consists of 19 items, self-completed with monitoring of previous month symptoms

ESS

A self-completed 8-item questionnaire with 0–3 rating on each item was used to determine the degree of daytime sleepiness

For pathologic sleepiness, a cut-off of 10/11 is used

ISCS

Consists of 6 items, clinician-administered

SSS

Calculating magnitude at a certain point in time

8

Apathy

AES

Based on an 18-item Likert scale

4 items scored solely by the patient, 1 item scored solely by the rater

AS

Abridged AES, which was developed for PD and has a 4-point Likert scale of 14 items, was used in treatment trials

Patient's score (items are read to patient)

LARS

In therapy trials, 33 items are used to screen for apathy

Structured interview with yes/no

9

Anhedonia

SHPS

Followed by 14 items, self-completed

10

Smell

AHRS

Ability to smell by asking questions

UPSI

To quantify the olfactory function

11

Fatigue

FSS

After reading each phrase, the applicant must circle or round a number between 1 and 7

Self-administered, 9-item

A low value implies that the argument is not entirely true, while a high value indicates that it is

12

Pain

DN4

Interview problems and physical measurements are used

A score of > 4 was deemed positive on the test

VAS

To determine the severity of the pain

It varies from 0 (no pain) to 10 (extreme pain)

  1. NMS-Q NMS Questionnaire, NMS-S NMS scale, PDQ-39 PD questionnaire, SCOPA Scales for Outcomes in PD, PD-CRS PD Cognitive Rating Scale, SCOPA-CS SCOPA-Cognitive subscale, MoCA Montreal Cognitive Assessment, Ham-D Hamilton Depression Index, BDI Beck Depression Inventory, MADRS Montgomery–Asberg Depression Rating Scale, GDS Geriatric Depression Scale, STAI State–Trait Anxiety Inventory, PDSS PD Sleep Scale, SCOPA-SS Scales for Outcomes in PD- sleep subscale, PSQI Pittsburgh Sleep Quality Index, ESS Epworth Sleepiness Scale, ISCS Inappropriate Sleep Composite Score, SSS Stanford Sleepiness Scale, AES Apathy Evaluation Scale, AS Apathy Scale, LARS Lille Apathy Rating Scale, SHPS Snaith–Hamilton Pleasure Scale, AHRS Argentina Hyposmia Rating Scale, UPSIT University of Pennsylvania smell identification test, FSS Fatigue Severity Scale, DN4 Douleur Neuropathique-4 Questionnaire, VAS visual analogue scale